Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3397390
Max Phase: Preclinical
Molecular Formula: C34H30F3N3O5S
Molecular Weight: 649.69
Molecule Type: Small molecule
Associated Items:
ID: ALA3397390
Max Phase: Preclinical
Molecular Formula: C34H30F3N3O5S
Molecular Weight: 649.69
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1cc2c(cc1S(=O)(=O)N1CCN(c3ccc(C(F)(F)F)cc3)CC1)N(CC(=O)c1ccc(-c3ccccc3)cc1)C(=O)CO2
Standard InChI: InChI=1S/C34H30F3N3O5S/c1-23-19-31-29(40(33(42)22-45-31)21-30(41)26-9-7-25(8-10-26)24-5-3-2-4-6-24)20-32(23)46(43,44)39-17-15-38(16-18-39)28-13-11-27(12-14-28)34(35,36)37/h2-14,19-20H,15-18,21-22H2,1H3
Standard InChI Key: ISUVYWSOAMKYQG-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 649.69 | Molecular Weight (Monoisotopic): 649.1858 | AlogP: 5.80 | #Rotatable Bonds: 7 |
Polar Surface Area: 87.23 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 0 |
#RO5 Violations: 2 | HBA (Lipinski): 8 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: 1.90 | CX LogP: 5.68 | CX LogD: 5.68 |
Aromatic Rings: 4 | Heavy Atoms: 46 | QED Weighted: 0.24 | Np Likeness Score: -1.56 |
1. Konda S, Raparthi S, Bhaskar K, Munaganti RK, Guguloth V, Nagarapu L, Akkewar DM.. (2015) Synthesis and antimicrobial activity of novel benzoxazine sulfonamide derivatives., 25 (7): [PMID:25754493] [10.1016/j.bmcl.2015.01.026] |
Source(1):